Sorafenib is a small-molecule multitargeted kinase inhibitor that blocks the activation of C-RAF , B-RAF , c-KIT , FLT-3 , RET , vascular endothelial growth factor receptor 2 ( VEGFR-2 ) , VEGFR-3 and platelet-derived growth factor receptor .
